Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Prosperini

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Brain reserve and timing of clinical onset in multiple sclerosisMaria Petracca, Serena Ruggieri, Riccardo Nistri, et al.
Clinical Neurology and Neurosurgery|October 26, 2024
Profile of antiplatelet regimens for emergent carotid stenting in tandem occlusion. Systematic review and meta-analysisGianluca De Rubeis, Luca Prosperini, Stefano Badia, et al.
International Journal of Pediatric Otorhinolaryngology|July 3, 2016
Level of emotion comprehension in children with mid to long term cochlear implant use: How basic and more complex emotion recognition relates to language and age at implantationPatrizia Mancini, Ilaria Giallini, Luca Prosperini, et al.
Frontiers in Neurology|November 8, 2021
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical CasesRiccardo Nistri, Elena Barbuti, Virginia Rinaldi, et al.
The Neuroradiology Journal|May 16, 2022
Non-traumatic acute myelopathies: Clinical and imaging features in a real world emergency settingAlessandro Stasolla, Luca Prosperini, Shalom Haggiag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical courseEmilia Sbardella, Anita Greco, Maria L Stromillo, et al.
European Journal of Physical and Rehabilitation Medicine|July 14, 2016
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measuresViviana Nociti, Luca Prosperini, Monica Ulivelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroadsLuca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.
The Laryngoscope|June 11, 2014
Prognostic factors of Bell's palsy: multivariate analysis of electrophysiological findingsPatrizia Mancini, Daniele De Seta, Luca Prosperini, et al.
Journal of the Neurological Sciences|June 2, 2017
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?Cristina Scarpazza, Luca Prosperini, Chiara R Mancinelli, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Brain reserve and timing of clinical onset in multiple sclerosisMaria Petracca, Serena Ruggieri, Riccardo Nistri, et al.
Clinical Neurology and Neurosurgery|October 26, 2024
Profile of antiplatelet regimens for emergent carotid stenting in tandem occlusion. Systematic review and meta-analysisGianluca De Rubeis, Luca Prosperini, Stefano Badia, et al.
International Journal of Pediatric Otorhinolaryngology|July 3, 2016
Level of emotion comprehension in children with mid to long term cochlear implant use: How basic and more complex emotion recognition relates to language and age at implantationPatrizia Mancini, Ilaria Giallini, Luca Prosperini, et al.
Frontiers in Neurology|November 8, 2021
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical CasesRiccardo Nistri, Elena Barbuti, Virginia Rinaldi, et al.
The Neuroradiology Journal|May 16, 2022
Non-traumatic acute myelopathies: Clinical and imaging features in a real world emergency settingAlessandro Stasolla, Luca Prosperini, Shalom Haggiag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical courseEmilia Sbardella, Anita Greco, Maria L Stromillo, et al.
European Journal of Physical and Rehabilitation Medicine|July 14, 2016
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measuresViviana Nociti, Luca Prosperini, Monica Ulivelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroadsLuca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.
The Laryngoscope|June 11, 2014
Prognostic factors of Bell's palsy: multivariate analysis of electrophysiological findingsPatrizia Mancini, Daniele De Seta, Luca Prosperini, et al.
Journal of the Neurological Sciences|June 2, 2017
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?Cristina Scarpazza, Luca Prosperini, Chiara R Mancinelli, et al.
Pageof 19